# Differential MRI atrophy profiles and incident dementia: A cross-national comparison

**Authors:** Monica E Walters, Brent J Small, Ross Andel, Ondrej Lerch, Hana Horakova, Victor A Molinari, Jason L Salemi, Martin Vyhnalek, Zuzana Nedelska, Jakub Hort

PMC · DOI: 10.1177/13872877251371734 · Journal of Alzheimer's Disease · 2025-09-03

## TL;DR

This study compares brain atrophy patterns in two countries and finds that the amount of atrophy, not specific regions, predicts the risk of developing Alzheimer's dementia.

## Contribution

The study identifies generalized atrophy profiles as predictors of Alzheimer's dementia risk across different populations.

## Key findings

- Four atrophy profiles were identified in the ADNI cohort, with higher atrophy levels linked to increased dementia risk.
- In the CBAS cohort, only two atrophy profiles were found, with severe atrophy showing a strong link to dementia risk.
- Baseline cognition reduced the predictive power of mild and severe atrophy in the two cohorts.

## Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder with extensive neuropathological and clinical heterogeneity.

We assessed empirically derived brain atrophy profiles in relation to incident AD dementia.

A secondary data analysis of two prospective cohort studies was conducted, including participants without dementia from the Alzheimer's Disease Neuroimaging Initiative (ADNI; n = 1703) and the Czech Brain Aging Study (CBAS; n = 385). Latent profile analysis identified profiles across 10 pre-selected, AD-related brain regions derived from structural magnetic resonance imaging (hippocampus, middle temporal, superior temporal, precuneus, anterior cingulate, medial orbitofrontal, pericalcarine, precentral, lingual, caudate regions). Cox proportional hazards regression assessed how profiles related to incident AD dementia.

Four profiles emerged in ADNI: Minimal (n = 192), Mild (n = 691), Moderate (n = 567), and Severe (n = 253) Atrophy. Two profiles emerged in CBAS: Mild (n = 208) and Severe (n = 177) Atrophy. In ADNI, participants with Mild (HR = 3.11, 95% CI [1.43, 6.78]), Moderate (HR = 7.58, 95% CI [3.45, 16.68]), and Severe (HR = 16.95, 95% CI [7.39, 39.86]) Atrophy (versus Minimal) had increased incident AD dementia risk. In CBAS, participants with Severe Atrophy (versus Mild) had increased incident AD dementia risk (HR = 3.51, 95% CI [2.14, 5.77]). Controlling for baseline cognition attenuated effects for Mild (ADNI) and Severe (CBAS) Atrophy to non-significance.

In two geographically and culturally distinct samples, magnitude of atrophy, not pattern across regions, determined classification into profiles, which predicted incident AD dementia. Findings highlight generalized, rather than region-specific, atrophy patterns associated with AD, and underscore the clinical utility of brain volumetry in identifying those with elevated incident AD dementia risk.

## Linked entities

- **Diseases:** Alzheimer's disease (MONDO:0004975)

## Full-text entities

- **Diseases:** neurodegenerative disorder (MESH:D019636), 's disease (MESH:D004194), AD (MESH:D000544), brain atrophy (MESH:C566985), Atrophy (MESH:D001284), dementia (MESH:D003704)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12550212/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12550212/full.md

## References

62 references — full list in the complete paper: https://tomesphere.com/paper/PMC12550212/full.md

---
Source: https://tomesphere.com/paper/PMC12550212